Akebia Therapeutics Inc. (AKBA)
NASDAQ: AKBA
· Real-Time Price · USD
3.24
-0.05 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
3.25
0.31%
After-hours: Aug 15, 2025, 07:55 PM EDT
Akebia Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 57.34M | 46.5M | 37.43M | 43.65M | 32.61M | 56.2M | 42.05M | 56.38M | 40.13M | 55.18M | 48.96M | 126.76M | 61.7M | 59.6M | 48.76M | 52.91M | 52.3M |
Cost of Revenue | 7.63M | 20.36M | 14.16M | 17.45M | 11.97M | 19.06M | 18.01M | 17.28M | 19.48M | 2.06M | 37.95M | 18.6M | 31.34M | 50.35M | 15.94M | 52.49M | 34.61M |
Gross Profit | 49.71M | 26.13M | 23.27M | 26.2M | 20.64M | 37.14M | 24.04M | 39.09M | 20.64M | 53.13M | 11.02M | 108.16M | 30.36M | 9.26M | 32.81M | 418K | 17.7M |
Operating Income | 13.51M | -14.31M | -12.51M | -8.72M | -14.88M | 1.37M | -13.04M | -9M | -24.83M | -5.13M | -47.99M | 48.84M | -58.49M | -66.16M | -54.89M | -79.34M | -64.94M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 6.11M | -22.8M | -20.04M | -8.58M | -17.98M | 613K | -14.49M | -11.17M | -26.22M | -7.55M | -51.87M | 29.28M | -62.42M | -70.68M | -59.54M | -83.04M | -69.58M |
Net Income | 6.11M | -22.8M | -20.04M | -8.58M | -17.98M | 614K | -14.49M | -11.17M | -16.74M | -8.76M | -55.74M | 29.28M | -66.35M | -70.68M | -59.54M | -83.04M | -69.58M |
Selling & General & Admin | 25.74M | 27.68M | 26.52M | 27.68M | 26.15M | 26.29M | 22.71M | 27.04M | 25.22M | 29.91M | 31.66M | 33.7M | 45.02M | 44.8M | 47.23M | 42.55M | 42.02M |
Research & Development | 9.75M | 11.79M | 8.49M | 7.25M | 9.37M | 9.47M | 13.33M | 20.2M | 19.69M | 31.9M | 27.35M | 26.03M | 43.83M | 29.56M | 40.47M | 37.21M | 40.61M |
Other Expenses | n/a | 978K | 769K | -39K | 95K | n/a | -43K | -1.65M | 568K | -1.2M | n/a | 411K | n/a | -4.52M | 427K | n/a | 161K |
Operating Expenses | 35.5M | 40.44M | 35.77M | 34.93M | 35.52M | 35.76M | 36.9M | 48.18M | 45.48M | 63.4M | 59.01M | 59.73M | 88.85M | 75.41M | 87.7M | 79.76M | 82.63M |
Interest Expense | -7.77M | 6.88M | 6.66M | 2.15M | 2.5M | 1.42M | 1.41M | 1.64M | 1.56M | 1.64M | 3.95M | 5.04M | 5.06M | 5.08M | 5.08M | 4.96M | 4.8M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 25.44M | 22.71M | 27.04M | 25.22M | 6.7M | n/a | n/a | n/a | 8.2M | n/a | n/a | n/a |
Cost & Expenses | 43.12M | 60.8M | 49.93M | 52.37M | 47.48M | 54.82M | 54.91M | 65.47M | 64.96M | 60.31M | 96.96M | 78.33M | 120.19M | 125.76M | 103.64M | 132.25M | 117.24M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -1K | n/a | 94K | -9.48M | 1.2M | 3.87M | 4.63M | 3.93M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 235.5M | 218.7M | 210.35M | 209.71M | 204.96M | 189.9M | 188.31M | 186.82M | 184.77M | 183.99M | 183.88M | 183.6M | 179.6M | 174.65M | 173.78M | 161.33M | 153.82M |
Shares Outstanding (Diluted) | 241.6M | 218.7M | 210.35M | 209.71M | 204.96M | 190.5M | 188.31M | 186.82M | 184.77M | 183.99M | 183.88M | 190.38M | 179.6M | 175.61M | 173.78M | 161.33M | 153.82M |
EPS (Basic) | 0.03 | -0.11 | -0.1 | -0.04 | -0.09 | 0.00 | -0.08 | -0.06 | -0.09 | -0.05 | -0.3 | 0.16 | -0.37 | -0.4 | -0.34 | -0.51 | -0.45 |
EPS (Diluted) | 0.03 | -0.11 | -0.1 | -0.04 | -0.09 | 0.00 | -0.08 | -0.06 | -0.09 | -0.05 | -0.3 | 0.15 | -0.37 | -0.4 | -0.34 | -0.51 | -0.45 |
EBITDA | 13.51M | -6.58M | -4M | 2.98M | -6.11M | 12.36M | -3.67M | -499K | -15.91M | -1.08M | -40.72M | 43.32M | -48.49M | -56.57M | -45.42M | -69.04M | -55.74M |
EBIT | n/a | -15.93M | -13.38M | -6.43M | -15.49M | 2.03M | -13.08M | -9.53M | -25.32M | 7.78M | -50.14M | 34.31M | -57.36M | -68.01M | -54.46M | -78.08M | -64.78M |
Depreciation & Amortization | n/a | 9.35M | 9.37M | 9.41M | 9.38M | 9.4M | 9.41M | 9.03M | 8.83M | 8.82M | 8.8M | 9.01M | 8.87M | 9.03M | 9.03M | 9.04M | 9.03M |